Thomas Lindner1, Michael Helle2, Olav Jansen3, and Stephan Ulmer3,4
1University Hospital Hamburg-Eppendorf, Hamburg, Germany, 2Tomographic Imaging Department, Philips Research Laboratories, Hamburg, Germany, 3Department of Radiology and Neuroradiology, University Hospital Schleswig-Holstein, Kiel, Germany, 4Radiology, Kantonsspital Winterthur, Winterthur, Switzerland
Synopsis
In this study, the effects of separating the label and control condtion from an Arterial Spin Labeling dataset used for resting state mapping was investigated and no differences between the label and the control condition could be found.
Introduction
Resting state functional MRI (rs-fMRI) allows for the
visualization of default mode networks contributing to identify important
functional brain areas. Generally, image acquisition is performed using BOLD
Echo-planar imaging (EPI). Recently, Arterial Spin Labeling (ASL) data was used
to map resting state default mode networks [1]. Pseudo continuous ASL (pCASL)
is based on two image acquisitions, i.e. a “label” with application of multiple
inversion pulses and a “control” with the same pulses but without net
inversion. This signal difference of blood forms the base of ASL perfusion imaging.
This alteration is only on the scale of 1-2% during
image acquisition [2]. However, this might be enough to change the outcome of
the independent component analysis (ICA) and in further consequence lead to
misinterpretation of the results. This study aims to investigate this effect.Materials and Methods
The patient population consisted of 15 patients (4
women, 11 men, mean age 51.4 years) suffering from Glioblastoma Multiforme
(GBM). The patient collective underwent pre- intra- and postoperative ASL MRI. More
details about the population can be found in [2]. In this study, the intraoperative
images have been used exclusively as the patients were anesthetized eliminating
any movement during scanning. All scans were acquired on a 1.5T scanner
(Philips Intera, Philips Healthcare, Best, The Netherlands) using a two 1-channel
loop coils. The study was approved by the local ethics committee. The pCASL scan
parameters included: 1800ms labeling duration and post labeling delay, 2D
multislice EPI scanning with 3.6x3.5x5mm³ resolution, TR/TE: 2616/13ms, 40
label/control pairs. These were separated in 40 label and 40 control images for
post-processing. This was performed using the MELODIC toolbox of FSL (FMRIB,
Oxford, UK) as described in [1].Results and Discussion
The results from post-processing of the individual
label and control datasets show only subtle differences which can be attributed
to noise. The ICA shows the same activation patterns with no differences in
their size or location. There are only faint differences in intensity (see colorbars
in figure 1). An example of the same 10 slices of control (a) and label (b) of
one example patient are shown in figure 1. The signal that could be obtained by
the separated datasets is smaller than in the full dataset taking both, label
and control pairs into account (Figure 2).Conclusion
Using
pCASL to identify resting state networks by ICA does not appear to be
influenced by the differences of the tagging pulses in the label and control
condition. Therefore, all the acquired data can be used for post-processing
which in further consequence increases the statistical power of the results and
leads to more clear definition of activation areas.Acknowledgements
No acknowledgement found.References
[1] Chen JJ, Jann K, Wang DJ. Characterizing Resting-State Brain Function Using
Arterial Spin Labeling. Brain Connect. 2015;5(9):527-542.
doi:10.1089/brain.2015.0344
[2] Alsop DC, Detre JA, Golay X, et al. Recommended
implementation of arterial spin-labeled perfusion MRI for clinical applications:
A consensus of the ISMRM perfusion study group and the European consortium for
ASL in dementia. Magn
Reson Med. 2015;73(1):102-116. doi:10.1002/mrm.25197
[3] Lindner T, Ahmeti H, Juhasz J, et al. A comparison of
arterial spin labeling and dynamic susceptibility perfusion imaging for
resection control in glioblastoma surgery. Oncotarget. 2018;9(26):18570-18577.
Published 2018 Apr 6. doi:10.18632/oncotarget.24970